Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  HYPERTENSION

• Publication date

  1983-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.5.5.772PMID 6352483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autonomic and psychic effects of yohimbine hydrochloride

  2004cited by this paper
• Comparative study of the effect of azepexole and clonidine on blood pressure and pulse rate in normotensive subjects

  2004cited by this paper
• Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor.

  1983cited by this paper
• Clonidine‐induced potentiation of reflex vagal bradycardia in anaesthetized cats

  1982cited by this paper
• Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbine

  1982cited by this paper
• Depression of reflex vagal bradycardia by a central action of phentolamine in the spinal cat.

  1982cited by this paper
• Depression of reflex vagal bradycardia by a central action of phentolamine in the spinal cat.

  1982cited by this paper
• Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.

  1982cited by this paper
• THE ROLE OF PRESYNAPTIC α‐ADRENOCEPTORS IN THE REGULATION OF BLOOD PRESSURE IN THE CONSCIOUS RABBIT

  1982cited by this paper
• Presynaptic alpha receptors in relation to the cardiovascular effect of yohimbine in the anesthetized cat.

  1981cited by this paper
• Role of alpha 1- and alpha 2-adrenoceptors in the modulation of the baroreflex vagal bradycardia.

  1981cited by this paper
• Alpha 1- and alpha 2-adrenoceptors: pharmacology and clinical implications.

  1981cited by this paper
• Regulation of norepinephrine release by peripheral α2‐receptor stimulation

  1981cited by this paper
• alpha-Adrenergic receptors in human adipocyte membranes: direct determination by [3H]yohimbine binding.

  1981cited by this paper
• Regulation of norepinephrine release by peripheral alpha 2-receptor stimulation.

  1981cited by this paper
• INTERACTION OF SELECTIVE α‐ADRENOCEPTOR AGONISTS AND ANTAGONISTS WITH HUMAN AND RABBIT BLOOD PLATELETS

  1980cited by this paper
• Evaluation of presynaptic alpha-receptor function in the canine renal vascular bed.

  1980cited by this paper
• Pharmacological evidence for a functional role of the prejunctional alpha-adrenoreceptor in noradrenergic neurotransmission in the conscious rat

  1980cited by this paper
• [Treatment of orthostatic hypotension induced by tricyclic antidepressants with yohimbine (author's transl)].

  1980cited by this paper
• Comparative Assessment of Stimuli That Release Neuronal and Adrenomedullary Catecholamines in Man

  1979cited by this paper
• Central alpha-adrenergic systems as targets for hypotensive drugs.

  1978cited by this paper
• Central α-adrenergic systems as targets for hypotensive drugs

  1978cited by this paper
• PRESYNAPTIC RECEPTORS AND THEIR ROLE IN THE REGULATION OF TRANSMITTER RELEASE.

  1977cited by this paper
• SIXTH GADDUM MEMORIAL LECTURE NATIONAL INSTITUTE FOR MEDICAL RESEARCH, MILL HILL, JANUARY 1977

  1977cited by this paper
• Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.

  1977cited by this paper
• A functional basis for classification of alpha-adrenergic receptors.

  1977cited by this paper
• A functional basis for classification of α-adrenergic receptors

  1977cited by this paper
• Clinical pharmacology and pharmacokinetics of clonidine

  1976cited by this paper
• The role of the central nervous system in the cardiovascular responses to yohimbine.

  1975cited by this paper
• THE PRESSOR ACTION OF YOHIMBINE AND QUEBRACHINE

  1933cited by this paper

• PET imaging of cardiac sympathetic nervous system dysfunction using meta-[18F]fluorobenzylguanidine.

  2025cites this paper
• No effect of glucocorticoid and noradrenergic activity on consistency in prosocial choice.

  2025cites this paper
• Study on the interaction of Yohimbine with duplex oligonucleotide using spectroscopic and computational tools

  2025cites this paper
• Impact of yohimbine on myoglobin stability: insights from molecular spectroscopic, and computational approaches

  2024cites this paper
• Oxytocin Reduces Noradrenergic-Induced Opioid-Like Withdrawal Symptoms in Individuals on Opioid Agonist Therapy

  2024cites this paper
• Ergogenic and Sympathomimetic Effects of Yohimbine: A Review

  2024cites this paper
• Exothermic binding and structural alteration of the carrier protein lysozyme induced by Yohimbine: A spectroscopic, calorimetric and cheminformatic insight

  2023cites this paper
• Effects of Acute Yohimbine Hydrochloride Supplementation on Repeated Supramaximal Sprint Performance

  2022cites this paper
• Effects of Acute Yohimbine Hydrochloride Ingestion on Bench Press Performance in Resistance-Trained Males

  2022cites this paper
• Comparison of TWA and PEP as indices of α2- and ß-adrenergic activation

  2022cites this paper
• PROTEIN BINDING CHARACTERISTICS OF YOHIMBINE, A NATURAL INDOLE ALKALOID BASED DRUG FOR ERECTILE DYSFUNCTION.

  2022cites this paper
• Methods of Laboratory Evaluation of the Autonomic Nervous System in Wakefulness and Sleep

  2021cites this paper
• Application of the PET ligand [11C]ORM-13070 to examine receptor occupancy by the α2C-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain

  2020cites this paper
• Application of the ligand 11 C-ORM-13070 to examine receptor by the selective -adrenoceptor antagonist validation of

  2020cites this paper
• (Lack of) Effects of noradrenergic stimulation on human working memory performance

  2020cites this paper
• Central Sympathetic Nervous System Effects on Cognitive-Motor Performance.

  2020cites this paper
• Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats.

  2020cites this paper
• Clinical neurophysiology of multiple system atrophy.

  2019cites this paper
• The impact of Yohimbine-induced arousal on facets of behavioural impulsivity

  2019cites this paper
• Reliability and robustness of feedback-evoked brain-heart coupling after placebo, dopamine, and noradrenaline challenge.

  2018cites this paper
• Cortisol boosts risky decision-making behavior in men but not in women.

  2017cites this paper
• Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease

  2017cites this paper
• A mánia a hangulat hipertóniája? Hasonlóságok és különbségek a bipoláris betegség és a hipertónia között

  2017cites this paper
• Is Mania the Hypertension of the Mood? Discussion of A Hypothesis

  2017cites this paper
• Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension

  2017cites this paper
• Cooling-evoked hemodynamic perturbations facilitate sympathetic activity with subsequent myogenic vascular oscillations via alpha2-adrenergic receptors.

  2017cites this paper
• Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarction.

  2016cites this paper
• Multiple system atrophy: Using clinical pharmacology to reveal pathophysiology

  2015cites this paper
• Understanding pain: How is pain processed in healthy humans?

  2014influential citation
• Histoire du concept d’anxiété : de la théorie des humeurs à la biologie moléculaire

  2014cites this paper
• Pure autonomic failure.

  2013cites this paper
• FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta.

  2013cites this paper
• Early-onset alcohol dependence increases the acoustic startle reflex.

  2012cites this paper
• Effect of the α(2)-adrenoceptor antagonist yohimbine on vascular regulation of the middle cerebral artery and the ophthalmic artery in healthy subjects.

  2011cites this paper
• Pharmacokinetics and pharmacodynamics of three intravenous doses of yohimbine in the horse.

  2011influential citation
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• The pharmacology of anxiety.

  2010cites this paper
• Potential novel anxiolytic drugs.

  2008cites this paper
• Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans.

  2008influential citation
• The acute effects of the thermogenic supplement Meltdown on energy expenditure, fat oxidation, and hemodynamic responses in young, healthy males

  2008cites this paper
• Chapter 5.2 How effective are current drug treatments for anxiety disorders, and how could they be improved?

  2008cites this paper
• Journal of the International Society of Sports Nutrition Open Access the Effects of Phosphatidylserine on Endocrine Response to Moderate Intensity Exercise

  2008cites this paper
• Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects

  2008cites this paper
• Yohimbine Attenuates Baroreflex-Mediated Bradycardia in Humans

  2007cites this paper
• Effects of glucagon‐like peptide‐1 and sympathetic stimulation on gastric accommodation in humans 1

  2007cites this paper
• Cardiovascular reactivity to mental stress is not affected by alpha2-adrenoreceptor activation or inhibition

  2006cites this paper
• Etude du rôle des récepteurs GABA dans l'anxiété, la dépression et l'addiction : approche pharmacologique et génétique

  2006cites this paper
• Ca2-Receptor-Mediated Vasoconstriction in Patients With Congestive Heart Failure

  2005cites this paper
• Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance

  2005cites this paper
• Effects of Natural Health Products on Blood Pressure

  2005cites this paper
• Herbs and alternative therapies: Relevance to hypertension and cardiovascular diseases

  2005cites this paper
• Clinical Studies Estimation of Intrasynaptic Norepinephrine Concentrations in Humans

  2005cites this paper
• The mechanism of yohimbine-induced renin release in the conscious rat

  2004cites this paper
• Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism.

  2004cites this paper
• Three Paradigms of Emotional Learning Differentially Affect Brainstem, Hypothalamic, and Limbic Circuits in the Rat

  2004cites this paper
• Effects of atipamezole--a selective alpha-adrenoceptor antagonist--on cardiac parasympathetic regulation in human subjects.

  2004cites this paper
• Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers

  2004cites this paper
• Orthostatic Hypotension:

  2003cites this paper
• AUTONOMIC DYSFUNCTION: DIAGNOSIS GUIDED BY THERAPY***

  2003cites this paper
• Left ventricular ejection time: a potential determinant of pulse wave velocity in young, healthy males

  2003cites this paper
• Adverse effects of herbal treatment of cardiovascular disease: what the physician must know.

  2001cites this paper
• OPC-28326, a Selective Femoral Vasodilator, Is an (cid:1) 2C -Adrenoceptor-Selective Antagonist

  2001cites this paper
• Yohimbine: a clinical review.

  2001cites this paper
• OPC-28326, a selective femoral vasodilator, is an alpha2C-adrenoceptor-selective antagonist.

  2001cites this paper
• Herbs and alternative therapies in the hypertension clinic.

  2001cites this paper
• OPC-28326, a Selective Femoral Vasodilator, Is an α2C-Adrenoceptor-Selective Antagonist

  2001cites this paper
• α2‐adrenoceptor antagonist properties of OPC‐28326, a novel selective peripheral vasodilator

  2001cites this paper
• Heredity and the autonomic nervous system in human hypertension

  2000cites this paper
• Glucose-induced sympathetic activity and energy expenditure during acute α2-adrenergic antagonism in obese subjects

  2000cites this paper
• α2‐adrenoceptor regulation of the hypothalamic‐pituitary‐adrenocortical axis in obesity

  2000cites this paper
• Hypertensive crisis from herbal treatment of impotence.

  1999cites this paper
• Adrenoceptors Mediating the Cardiovascular and Metabolic Effects of α-Methylnoradrenaline in Humans

  1999cites this paper
• [Therapy of orthostatic hypotension].

  1999cites this paper
• Black widow spider envenomation mimicking cholecystitis.

  1999cites this paper
• Neurally mediated syncope: pathophysiology and implications for treatment.

  1999cites this paper
• Adrenoceptors mediating the cardiovascular and metabolic effects of alpha-methylnoradrenaline in humans.

  1999cites this paper
• Expression of altered α2‐adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension

  1998cites this paper
• α2-Adrenoceptor Antagonists

  1998cites this paper
• Yohimbe Alkaloids – General Discussion

  1997cites this paper
• Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.

  1997cites this paper
• α2-Adrenergic modulation of colonic tone during hyperventilation.

  1997cites this paper
• Chinaberry poisoning in two dogs.

  1997cites this paper
• a 2-Adrenergic modulation of colonic tone during hyperventilation

  1997cites this paper
• Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine

  1997cites this paper
• Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans.

  1997cites this paper
• Effects of Yohimbine on Autonomic Measures are Determined by Individual Values for Area Under the Concentration—Time Curve

  1996cites this paper
• Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide.

  1996cites this paper
• Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha2‐adrenoceptor antagonist *

  1995cites this paper
• Yohimbine effects on blood pressure and plasma catecholamines in human hypertension.

  1995cites this paper
• Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system.

  1995cites this paper
• Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

  1995cites this paper
• The effects of a peripherally selective alpha 2-adrenoceptor antagonist, MK-467, on the metabolic and cardiovascular response to exercise in healthy man.

  1994cites this paper
• Laboratory diagnosis in hypertension

  1994cites this paper
• Parenteral exposure to detomidine and butorphanol.

  1994cites this paper
• Manipulation of Norepinephrine Metabolism with Yohimbine in the Treatment of Autonomic Failure

  1994cites this paper
• Oral Yohimbine Increases Blood Pressure and Sympathetic Nervous Outflow in Hypertensive Patients

  1993cites this paper
• The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.

  1993cites this paper
• Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.

  1993cites this paper
• The pharmacology of RS‐15385‐197, a potent and selective α2‐adrenoceptor antagonist

  1993cites this paper
• α2‐Adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine

  1993cites this paper